Chemoinformaics analysis of sulfinylbis- (CAS) Dimethyl sulfoxide
| Molecular Weight | 78.136 | nRot | 0 |
| Heavy Atom Molecular Weight | 72.088 | nRig | 0 |
| Exact Molecular Weight | 78.0139 | nRing | 0 |
| Solubility: LogS | 0.477 | nHRing | 0 |
| Solubility: LogP | -0.53 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 10 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 4 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 11.0428 |
| nHD | 0 | BPOL | 10.5772 |
| QED | 0.374 |
| Synth | 4.851 |
| Natural Product Likeliness | 0.113 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.191 |
| HIA | 0.012 |
| CACO-2 | -4.535 |
| MDCK | 0.0000591 |
| BBB | 0.491 |
| PPB | 0.19289 |
| VDSS | 1.092 |
| FU | 0.819707 |
| CYP1A2-inh | 0.206 |
| CYP1A2-sub | 0.806 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.848 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.173 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.42 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.327 |
| CL | 3.907 |
| T12 | 0.793 |
| hERG | 0.008 |
| Ames | 0.898 |
| ROA | 0.023 |
| SkinSen | 0.745 |
| Carcinogencity | 0.974 |
| EI | 0.98 |
| Respiratory | 0.57 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.947667 |